Oxycodone HCL-Acetaminophen Tablets
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
Award Notice Oxycodone HCL-Acetaminophen Tablets
SPE2D2-22-D-0150 P00009 to invoke Option Year 4
SPE2D2-22-D-0150 P00008 - This modification hereby incorporates the attached bilateral agreement incorporating clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026).
SPE2D2-22-D-0150 P00007 to invoke Option Year 3
SPE2D2-22-D-0150 P00006 Mass Modification based on Executive Orders.
SPE2D2-22-D-0150 P00005 to invoke Option Year 2
SPE2D2-22-D-0150 P00003 to invoke Option Year 1
SPE2D2-22-D-0150 P00002 To incorporate Drug Supply Chanin Act (DCSA) language into solicitation for subject contract.
SPE2D2-22-D-0150 P00001 To incorporate FAR 52.204-27 Prohibtion on a Bytedance Covered Application (June 2023) into subject contract.
Oxycodone HCL/Acetaminophen Tablets contract award SPE2D2-22-D-0150 Line Items 0001 through 0005.
Related Procurement Opportunities
Similar tenders in Pharmaceuticals, Healthcare Equipment and Services, Chemicals